HIC
Hartline Investment Corp Portfolio holdings
AUM
$881M
This Quarter Return
+2.78%
1 Year Return
+36.2%
3 Year Return
+150.72%
5 Year Return
+312.52%
10 Year Return
+924.17%
AUM
$306M
AUM Growth
+$306M
(+2.2%)
Cap. Flow
+$5.31M
Cap. Flow
% of AUM
1.73%
Top 10 Holdings %
Top 10 Hldgs %
45.34%
Holding
113
New
5
Increased
30
Reduced
45
Closed
6
Top Buys
| 1 |
DXGE
WisdomTree Germany Hedged Equity Fund
DXGE
|
$5.84M |
| 2 |
Gentex
GNTX
|
$2.49M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$1.64M |
| 4 |
Schwab International Equity ETF
SCHF
|
$1.54M |
| 5 |
Walt Disney
DIS
|
$1.45M |
Top Sells
| 1 |
MWIV
MWI VETERINARY SUPPLY, INC.
MWIV
|
$1.37M |
| 2 |
Amgen
AMGN
|
$920K |
| 3 |
SP
SP Plus Corporation
SP
|
$802K |
| 4 |
Middleby
MIDD
|
$641K |
| 5 |
Alibaba
BABA
|
$598K |
Sector Composition
| 1 | Financials | 29.06% |
| 2 | Industrials | 13.07% |
| 3 | Technology | 9.83% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Healthcare | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDS.A
101
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $220K | 0.07% | 3,695 | – | – |
|
102
Colgate-Palmolive
CL
$67.9B
| $217K | 0.07% | 3,130 | – | – |
|
103
iShares Biotechnology ETF
IBB
$5.6B
| $217K | 0.07% | 632 -87 | -12% | -$29.9K |
|
104
Johnson & Johnson
JNJ
$427B
| $209K | 0.07% | 2,073 +30 | +1% | +$3.03K |
|
105
Pfizer
PFE
$141B
| $205K | 0.07% | +5,900 | New | +$205K |
|
106
Kimberly-Clark
KMB
$42.8B
| – | – | -1,790 | Closed | -$207K |
|
107
Schwab Emerging Markets Equity ETF
SCHE
$10.7B
| – | – | -12,348 | Closed | -$295K |
|
108
AT&T
T
$209B
| – | – | -8,297 | Closed | -$279K |
|
|
MWIV
109
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| – | – | -8,084 | Closed | -$1.37M |
|
|
110
Alibaba
BABA
$322B
| – | – | -5,750 | Closed | -$598K |
|